Onconetix, Inc. (ONCO) Sets 1-for-10 Reverse Split Effective Nov. 6

What happened

Onconetix approved a 1-for-10 reverse stock split effective 12:01 a.m. ET on Nov. 6, 2026, cutting outstanding shares from about 5,886,774 to about 588,677. Shares keep trading on Nasdaq under ONCO, with a new CUSIP 68237Q500.

Confirmed

Global impact / market context

A reverse split raises the price of each share by cutting the number of shares, which can help a small company meet Nasdaq's minimum price rule for listing. Fewer shares may also reduce trading activity and make the stock price jump more on small trades.

Analyst inference

This is a common step for small public companies trying to lift their share price and keep their Nasdaq listing. The article says authorized shares stay unchanged, which means the company could still issue many new shares later and dilute current owners.

Analyst inference

What to watch

1. The split takes effect at 12:01 a.m. ET on Nov. 6, 2026, reducing shares to about 588,677 from about 5,886,774, while the ticker stays ONCO and the new CUSIP is 68237Q500. Confirmed
2. No fractional shares will be issued; holders who would receive a partial share get cash instead, which could cash out some small investors and slightly change who owns the stock. Confirmed
3. Watch whether Onconetix confirms Nasdaq compliance after the split and whether it raises new money or issues shares, since authorized shares stay unchanged and could dilute owners. Analyst inference

Evidence

• globenewswire.com